Faron Pharmaceuticals

company

About

Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
€2.50M
Industries
Biopharma,Biotechnology,Medical,Pharmaceutical
Founded date
Oct 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.50M
Faron Pharmaceuticals has raised a total of €2.50M in funding over 2 rounds. Their latest funding was raised on Jun 11, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 11, 2020 Grant €2.50M 1 European Innovation Council Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Faron Pharmaceuticals is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant